Stratasys, CollPlant Unite Technologies for Industrial-Scale Bioprinting of Tissues, Organs
The joint development and commercialization agreement will initially focus on development of a bioprinting solution for CollPlant’s regenerative breast implants, addressing $2.6 billion market opportunity.
Share
Read Next
Stratasys and CollPlant Biotechnologies are collaborating on the development of a solution for bio-fabrication human tissues and organs using Stratasys’ P3 technology-based bioprinter and CollPlant’s rh-Collagen-based bioinks. The first project focuses on the development of an industrial-scale solution for CollPlant’s regenerative breast implants program.
Stratasys will provide its expertise in polymer 3D printing solutions for CollPlant, which is a regenerative and aesthetics medicine company developing technologies and products based on its plant-based collagen for tissue regeneration and organ manufacturing.
The bioprinter is based on Stratasys’ precise P3 3D printing technology in combination with CollPlant's flagship bioinks. The printer will enable the production of CollPlant’s breast implants, which are being designed to regenerate an individual’s natural breast tissue without eliciting immune response, providing a potentially revolutionary alternative for both aesthetic and reconstructive procedures.
Currently, the global breast implant market is estimated to be $2.6 billion, with breast reconstruction and augmentation procedures representing the second most common plastic surgery procedure performed worldwide. The most common breast augmentation or reconstruction procedures today are based on synthetic silicone breast implantations, which is an artificial substitution for natural regenerated tissue and has risks of complications.
As part of the collaboration, both companies have agreed to cross-promote each other’s bioprinting products. Stratasys’s bioprinter will be offered to customers together with CollPlant’s bioinks and, similarly, Stratasys’ bioprinter will be offered to CollPlant’s business partners and customers.
“Through this partnership with CollPlant, we have an important opportunity to transform health care with bioprinting to improve the lives of patients undergoing breast augmentation or reconstruction procedures,” says Stratasys CEO Dr. Yoav Zeif. “This agreement is well aligned with our strategy to deliver complete solutions for high-growth industry applications with our ecosystem of partners, and the production scale and precision 3D printing capabilities of Stratasys’ P3 Programmable Photopolymerization technology are a particularly strong fit for bioprinting applications.”
The partnership is focused on accelerating the industrialization of bioprinting for regenerative medicine. “Stratasys is leading in additive manufacturing and we are excited to collaborate ith them on this transformative initiative,” says Yehiel Tal, CollPlant CEO. “The P3 technology allows printing with high resolution and process control, and we believe that the combined, pioneering technologies of both companies will streamline the development and production process so that we have the most efficient means to produce our regenerative breast implants, and other potential tissues and organs. We believe that our rhCollagen-based regenerative implant has the potential to overcome the challenges of existing breast procedures that use silicone implants or autologous fat tissue transfer.”
In January 2023, CollPlant announced that it successfully completed a large-animal study for its 3D bioprinted regenerative breast implants. The preclinical study demonstrated progressive stages of tissue regeneration after three months, as highlighted by the formation of maturing connective tissue and neovascular networks within the implants, with no adverse events reported. Based on these positive results, CollPlant is planning to initiate a followup, large-animal study in the second half of 2023 using commercial-size implants to support subsequent human studies and future product commercialization.
- Read about the Stratasys partnership with Ricoh for print-on-demand medical models. This offering gives clinicians and patients increased access to patient-specific, 3D printed models for pre-operative surgical planning, diagnostic use and surgical education to improve clinical outcomes and drive significant savings through improved productivity.
- Learn how Stratasys’ innovation extends to moviemaking for 3D printed camera components used to capture “Avatar: The Way of Water” film. SNL Creative used AM materials from Stratasys and other providers to create stereoscopic camera rigs used by the production team during the creation of the new Avatar film. The custom-designed camera components met the rigorous requirements for filming and offered a modernized alternative for future film usage.
Related Content
3D Printed Lattices Replace Foam for Customized Helmet Padding: The Cool Parts Show #62
“Digital materials” resulting from engineered flexible polymer structures made through additive manufacturing are tunable to the application and can be tailored to the head of the wearer.
Read MoreQ&A With Align EVP: Why the Invisalign Manufacturer Acquired Cubicure, and the Future of Personalized Orthodontics
Align Technology produces nearly 1 million unique aligner parts per day. Its acquisition of technology supplier Cubicure in January supports demand for 3D printed tooling and direct printed orthodontic devices at mass scale.
Read MoreLarge-Format “Cold” 3D Printing With Polypropylene and Polyethylene
Israeli startup Largix has developed a production solution that can 3D print PP and PE without melting them. Its first test? Custom tanks for chemical storage.
Read MoreWhat Does Additive Manufacturing Readiness Look Like?
The promise of distributed manufacturing is alluring, but to get there AM first needs to master scale production. GKN Additive’s Michigan facility illustrates what the journey might look like.
Read MoreRead Next
3MF File Format for Additive Manufacturing: More Than Geometry
The file format offers a less data-intensive way of recording part geometry, as well as details about build preparation, material, process and more.
Read MoreHow Avid Product Development Creates Efficiencies in High-Mix, Low-Volume Additive Manufacturing
Contract manufacturer Avid Product Development (a Lubrizol company) has developed strategies to streamline part production through 3D printing so its engineering team can focus on development, design, assembly and other services.
Read MoreNew Equipment, Additive Manufacturing for Casting Replacement and AM's Next Phase at IMTS 2024: AM Radio #54
Additive manufacturing’s presence at IMTS – The International Manufacturing Technology Show revealed trends in technology as well as how 3D printing is being applied today and where it will be tomorrow. Peter Zelinski and I share observations from the show on this episode of AM Radio.
Read More